{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T12:59:17Z","timestamp":1781182757262,"version":"3.54.1"},"reference-count":39,"publisher":"Informa UK Limited","issue":"1","license":[{"start":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T00:00:00Z","timestamp":1781136000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"Clinical Medicine Fund of Jiangsu University","award":["JDLCZX013"],"award-info":[{"award-number":["JDLCZX013"]}]}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Journal of Enzyme Inhibition and Medicinal Chemistry"],"published-print":{"date-parts":[[2026,12,31]]},"DOI":"10.1080\/14756366.2026.2684700","type":"journal-article","created":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T12:19:42Z","timestamp":1781180382000},"update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":0,"title":["Discovery of a novel and potent KRAS\n                    <sup>G12V<\/sup>\n                    -targeting peptide with antiproliferative activity against colorectal cancer cells"],"prefix":"10.1080","volume":"41","author":[{"given":"Hai","family":"Zhang","sequence":"first","affiliation":[{"name":"Department of Hepatobiliary Surgery, The Affiliated Hospital of Jiangsu University","place":["Zhenjiang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shudan","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Analysis, China Pharmaceutical University","place":["Nanjing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuting","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Analysis, China Pharmaceutical University","place":["Nanjing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miao-Miao","family":"Niu","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Analysis, China Pharmaceutical University","place":["Nanjing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingjiang","family":"She","sequence":"additional","affiliation":[{"name":"Department of Gastrointestinal Surgery, Jintan Affiliated Hospital of Jiangsu University","place":["Changzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2026,6,11]]},"reference":[{"key":"e_1_3_3_2_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.tranon.2021.101174"},{"issue":"1","key":"e_1_3_3_3_1","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1186\/s12967-024-05391-5","article-title":"Novel hypoxia- and lactate metabolism-related molecular subtyping and prognostic signature for colorectal cancer","volume":"22","author":"Huang A","year":"2024","unstructured":"Huang A, Sun Z, Hong H, Yang Y, Chen J, Gao Z, Gu J. Novel hypoxia- and lactate metabolism-related molecular subtyping and prognostic signature for colorectal cancer. J Transl Med. 2024;22(1):587.","journal-title":"J Transl Med"},{"issue":"1","key":"e_1_3_3_4_1","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1186\/s13046-025-03338-2","article-title":"Genome-wide CRISPR screening identifies PHF8 as an effective therapeutic target for KRAS- or BRAF-mutant colorectal cancers","volume":"44","author":"Liu Z","year":"2025","unstructured":"Liu Z, Li Y, Wang S, Wang Y, Sui M, Liu J, Chen P, Wang J, Zhang Y, Dang C, et al. Genome-wide CRISPR screening identifies PHF8 as an effective therapeutic target for KRAS- or BRAF-mutant colorectal cancers. J Exp Clin Cancer Res. 2025;44(1):70.","journal-title":"J Exp Clin Cancer Res"},{"key":"e_1_3_3_5_1","doi-asserted-by":"publisher","DOI":"10.1080\/17568919.2025.2557177"},{"key":"e_1_3_3_6_1","doi-asserted-by":"publisher","DOI":"10.1186\/s40164-025-00637-4"},{"issue":"2","key":"e_1_3_3_7_1","doi-asserted-by":"crossref","first-page":"101966","DOI":"10.1016\/j.xcrm.2025.101966","article-title":"KRAS(G12D)-driven pentose phosphate pathway remodeling imparts a targetable vulnerability synergizing with MRTX1133 for durable remissions in PDAC","volume":"6","author":"Jiang X","year":"2025","unstructured":"Jiang X, Wang T, Zhao B, Sun H, Dong Y, Ma Y, Li Z, Wu Y, Wang K, Guan X, et al. KRAS(G12D)-driven pentose phosphate pathway remodeling imparts a targetable vulnerability synergizing with MRTX1133 for durable remissions in PDAC. Cell Rep Med. 2025;6(2):101966.","journal-title":"Cell Rep Med"},{"key":"e_1_3_3_8_1","doi-asserted-by":"publisher","DOI":"10.1021\/jacs.1c12075"},{"key":"e_1_3_3_9_1","doi-asserted-by":"publisher","DOI":"10.1158\/1535-7163.MCT-24-1173"},{"issue":"2","key":"e_1_3_3_10_1","doi-asserted-by":"crossref","first-page":"e174249","DOI":"10.1172\/JCI174249","article-title":"Targeted degradation of oncogenic KRASG12V triggers antitumor immunity in lung cancer models","volume":"135","author":"Li D","year":"2024","unstructured":"Li D, Geng K, Hao Y, Gu J, Kumar S, Olson AT, Kuismi CC, Kim HM, Pan Y, Sherman F, et al. Targeted degradation of oncogenic KRASG12V triggers antitumor immunity in lung cancer models. J Clin Invest. 2024;135(2):e174249.","journal-title":"J Clin Invest"},{"issue":"1","key":"e_1_3_3_11_1","doi-asserted-by":"crossref","first-page":"119872","DOI":"10.1016\/j.bbamcr.2024.119872","article-title":"Oncogenic KRAS mutations modulate BAX-mediated cell death","volume":"1872","author":"Ferreira A","year":"2025","unstructured":"Ferreira A, Manon S, Eyitayo AR, Chaves SR, C\u00f4rte-Real M, Preto A, Sousa MJ. Oncogenic KRAS mutations modulate BAX-mediated cell death. Biochim Biophys Acta Mol Cell Res. 2025;1872(1):119872.","journal-title":"Biochim Biophys Acta Mol Cell Res"},{"key":"e_1_3_3_12_1","doi-asserted-by":"crossref","first-page":"110272","DOI":"10.1016\/j.compbiomed.2025.110272","article-title":"Identification and characterization of oncogenic KRAS G12V inhibitory peptides by phage display, molecular docking and molecular dynamic simulation","volume":"192","author":"Saetang J","year":"2025","unstructured":"Saetang J, Yamabhai M, Rangnoi K, Prompat N, Haewphet T, Sangkhathat S, Tipmanee V, Benjakul S. Identification and characterization of oncogenic KRAS G12V inhibitory peptides by phage display, molecular docking and molecular dynamic simulation. Comput Biol Med. 2025;192(Pt A):110272.","journal-title":"Comput Biol Med"},{"issue":"6","key":"e_1_3_3_13_1","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/j.tips.2024.04.001","article-title":"Malolactone strikes: K-Ras-G12D\u2019s Achilles\u2019 heel","volume":"45","author":"Adamopoulos C","year":"2024","unstructured":"Adamopoulos C, Papavassiliou KA, Papavassiliou AG. Malolactone strikes: K-Ras-G12D\u2019s Achilles\u2019 heel. Trends Pharmacol Sci. 2024;45(6):472\u2013474.","journal-title":"Trends Pharmacol Sci"},{"key":"e_1_3_3_14_1","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jmedchem.1c01688"},{"key":"e_1_3_3_15_1","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-24-1757"},{"issue":"1","key":"e_1_3_3_16_1","doi-asserted-by":"crossref","first-page":"17730","DOI":"10.1038\/s41598-020-74610-y","article-title":"Neuron type-specific expression of a mutant KRAS impairs hippocampal-dependent learning and memory","volume":"10","author":"Ryu H-H","year":"2020","unstructured":"Ryu H-H, Kang M, Hwang K-D, Jang HB, Kim SJ, Lee Y-S. Neuron type-specific expression of a mutant KRAS impairs hippocampal-dependent learning and memory. Sci Rep. 2020;10(1):17730.","journal-title":"Sci Rep"},{"key":"e_1_3_3_17_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41417-022-00454-5"},{"issue":"6","key":"e_1_3_3_18_1","doi-asserted-by":"crossref","first-page":"3340","DOI":"10.1158\/1538-7445.AM2024-3340","article-title":"Abstract 3340: RMC-5127, a first-in-class, orally bioavailable mutant-selective RASG12V(ON) inhibitor is central nervous system (CNS)-penetrant and demonstrates anti-tumor activity in a preclinical intracranial xenograft model","volume":"84","author":"Chen Z","year":"2024","unstructured":"Chen Z, Eriksson A, Lee B, Dinglasan J, Montazer N, Cregg J, Edwards A, Sanders K, Smith JA, Wildes D, et al. Abstract 3340: RMC-5127, a first-in-class, orally bioavailable mutant-selective RASG12V(ON) inhibitor is central nervous system (CNS)-penetrant and demonstrates anti-tumor activity in a preclinical intracranial xenograft model. Cancer Research. 2024;84(6_Supplement):3340\u20133340.","journal-title":"Cancer Research"},{"issue":"6715","key":"e_1_3_3_19_1","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1126\/science.adm8684","article-title":"Targeting cancer with small-molecule pan-KRAS degraders","volume":"385","author":"Popow J","year":"2024","unstructured":"Popow J, Farnaby W, Gollner A, Kofink C, Fischer G, Wurm M, Zollman D, Wijaya A, Mischerikow N, Hasenoehrl C, et al. Targeting cancer with small-molecule pan-KRAS degraders. Science. 2024;385(6715):1338\u20131347.","journal-title":"Science"},{"issue":"10","key":"e_1_3_3_20_1","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1016\/j.ccell.2025.05.016","article-title":"A first-in-class EGFR-directed KRAS G12V selective inhibitor","volume":"43","author":"Stanland LJ","year":"2025","unstructured":"Stanland LJ, Huggins HP, Sahoo SS, Porrello A, Chareddy Y, Azam SH, Perry JL, Pallan PS, Whately K, Edatt L, et al. A first-in-class EGFR-directed KRAS G12V selective inhibitor. Cancer Cell. 2025;43(10):1815\u20131832.e10.","journal-title":"Cancer Cell"},{"issue":"8","key":"e_1_3_3_21_1","doi-asserted-by":"crossref","first-page":"4375","DOI":"10.1158\/1538-7445.AM2025-4375","article-title":"Abstract 4375: LY4066434, an oral small molecule pan-KRAS inhibitor, demonstrates robust anti-tumor activity in KRAS-mutant models, including in the CNS","volume":"85","author":"Gao H","year":"2025","unstructured":"Gao H, Zhang Y, Yu CP, Xu WG, Li B, Bian H, Tandon M, Wang T, Stewart TR, Bender MH, et al. Abstract 4375: LY4066434, an oral small molecule pan-KRAS inhibitor, demonstrates robust anti-tumor activity in KRAS-mutant models, including in the CNS. Cancer Research. 2025;85(8_Supplement_1):4375\u20134375.","journal-title":"Cancer Research"},{"issue":"4","key":"e_1_3_3_22_1","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1158\/2159-8290.CD-25-1280","article-title":"Discovery of BBO-11818, a potent and selective noncovalent inhibitor of (ON) and (OFF) KRAS with activity against multiple oncogenic mutants","volume":"16","author":"Stahlhut C","year":"2026","unstructured":"Stahlhut C, Maciag AE, Sullivan KA, Singh K, Gitego N, Zhang Z, Chan AH, Sharma AK, Alexander PA, Shu J, et al. Discovery of BBO-11818, a potent and selective noncovalent inhibitor of (ON) and (OFF) KRAS with activity against multiple oncogenic mutants. Cancer Discov. 2026;16(4):740\u2013759.","journal-title":"Cancer Discov"},{"key":"e_1_3_3_23_1","doi-asserted-by":"publisher","DOI":"10.3390\/cancers12061412"},{"key":"e_1_3_3_24_1","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.13566"},{"key":"e_1_3_3_25_1","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14194884"},{"issue":"1","key":"e_1_3_3_26_1","doi-asserted-by":"crossref","first-page":"29404","DOI":"10.1038\/s41598-025-15038-0","article-title":"In Silico discovery of novel androgen receptor inhibitors for prostate cancer therapy using virtual screening, molecular docking, and molecular dynamics simulations","volume":"15","author":"Huang X","year":"2025","unstructured":"Huang X, Hu J. In Silico discovery of novel androgen receptor inhibitors for prostate cancer therapy using virtual screening, molecular docking, and molecular dynamics simulations. Sci Rep. 2025;15(1):29404.","journal-title":"Sci Rep"},{"issue":"1","key":"e_1_3_3_27_1","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s12859-024-05991-4","article-title":"A comprehensive survey of scoring functions for protein docking models","volume":"26","author":"Shirali A","year":"2025","unstructured":"Shirali A, Stebliankin V, Karki U, Shi J, Chapagain P, Narasimhan G. A comprehensive survey of scoring functions for protein docking models. BMC Bioinformatics. 2025;26(1):25.","journal-title":"BMC Bioinformatics"},{"key":"e_1_3_3_28_1","doi-asserted-by":"publisher","DOI":"10.1002\/adhm.202002197"},{"key":"e_1_3_3_29_1","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jmedchem.3c02433"},{"key":"e_1_3_3_30_1","doi-asserted-by":"publisher","DOI":"10.1021\/acs.biochem.8b01300"},{"key":"e_1_3_3_31_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2017.02.006"},{"key":"e_1_3_3_32_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.peptides.2022.170814"},{"key":"e_1_3_3_33_1","doi-asserted-by":"publisher","DOI":"10.1080\/14756366.2026.2633822"},{"key":"e_1_3_3_34_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0012684"},{"key":"e_1_3_3_35_1","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jmedchem.3c01572"},{"key":"e_1_3_3_36_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41589-022-00985-w"},{"issue":"1","key":"e_1_3_3_37_1","doi-asserted-by":"crossref","first-page":"8969","DOI":"10.1038\/s41467-025-64648-9","article-title":"EGFR-STAT1 pathway drives fibrosis initiation in fibroinflammatory skin diseases","volume":"16","author":"Odell AV","year":"2025","unstructured":"Odell AV, Newton NM, Eisenstein A, Micevic G, Flavell RA, Odell ID. EGFR-STAT1 pathway drives fibrosis initiation in fibroinflammatory skin diseases. Nat Commun. 2025;16(1):8969.","journal-title":"Nat Commun"},{"issue":"1","key":"e_1_3_3_38_1","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1186\/s13046-018-0866-4","article-title":"HJURP promotes hepatocellular carcinoma proliferation by destabilizing p21 via the MAPK\/ERK1\/2 and AKT\/GSK3\u03b2 signaling pathways","volume":"37","author":"Chen T","year":"2018","unstructured":"Chen T, Huang H, Zhou Y, Geng L, Shen T, Yin S, Zhou L, Zheng S. HJURP promotes hepatocellular carcinoma proliferation by destabilizing p21 via the MAPK\/ERK1\/2 and AKT\/GSK3\u03b2 signaling pathways. J Exp Clin Cancer Res. 2018;37(1):193.","journal-title":"J Exp Clin Cancer Res"},{"key":"e_1_3_3_39_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.yexcr.2024.114361"},{"key":"e_1_3_3_40_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2024.216783"}],"container-title":["Journal of Enzyme Inhibition and Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/14756366.2026.2684700","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T12:19:45Z","timestamp":1781180385000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/14756366.2026.2684700"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,11]]},"references-count":39,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,12,31]]}},"alternative-id":["10.1080\/14756366.2026.2684700"],"URL":"https:\/\/doi.org\/10.1080\/14756366.2026.2684700","relation":{},"ISSN":["1475-6366","1475-6374"],"issn-type":[{"value":"1475-6366","type":"print"},{"value":"1475-6374","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,11]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ienz20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ienz20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2026-03-25","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-05-13","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-05-30","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-06-11","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"2684700"}}